Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease - 1 Jun 2022

Kaniga K, Lounis N, Zhuo S, Bakare N, Andries K

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Diarylquinolines
Share to Mutation
Share to Tuberculosis, Multidrug-Resistant

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Open in PubMed Open full text

Identifiers

PMID: 35650698
DOI: 10.5588/ijtld.21.0670
PMCID: PMC9165736

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline.PMID 35650698Read ↗

Mutations associated with in vitro resistance to bedaquiline in Mycobacterium tuberculosis isolates in Australia.Semantic proximity Read ↗

Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678Semantic proximity Read ↗

Bedaquiline resistant Mycobacterium tuberculosis clinical isolates with and without rv0678 mutations have similar growth patterns under varying BDQ drug pressure.Semantic proximity Read ↗

Site-directed mutagenesis of Mycobacterium tuberculosis and functional validation to investigate potential bedaquiline resistance-causing mutations.Semantic proximity Read ↗

Predicting MmpR-based bedaquiline resistance using sequence- and structure-based featuresSemantic proximity Read ↗

Analysis of genetic characteristics associated with reduced bedaquiline susceptibility in multidrug-resistant Mycobacterium tuberculosis.Semantic proximity Read ↗

Molecular analysis of bedaquiline resistance and genetic variations in clinical isolates of multidrug and fluoroquinolones-resistant Mycobacterium tuberculosisSemantic proximity Read ↗

Identification of genetic determinants of bedaquiline resistance in Mycobacterium tuberculosis in Ural region, RussiaSemantic proximity Read ↗

Feature-based in-silico model to predict the <i>Mycobacterium tuberculosis</i> bedaquiline phenotype associated with Rv0678 variantsSemantic proximity Read ↗

High frequency of bedaquiline resistance in programmatically treated drug-resistant TB patients with sustained culture-positivity in Cape Town, South AfricaSemantic proximity Read ↗

Whole Genome Sequencing Identifies Novel Mutations Associated With Bedaquiline Resistance in Mycobacterium tuberculosis.Semantic proximity Read ↗

Deciphering Bedaquiline and Clofazimine Resistance in Tuberculosis: An Evolutionary Medicine ApproachSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.